ID   HUMEMS
AC   CVCL_S872
DR   Wikidata; Q54896877
RX   PubMed=17547718;
RX   PubMed=20712710;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; 3819; FOXO1 + HGNC; 8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=17547718).
CC   Misspelling: HUMENS; PubMed=20712710.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
RX   PubMed=17547718; DOI=10.1111/j.1749-0774.2007.00029.x;
RA   Ohi S.;
RT   "Characterization, anticancer drug susceptibility and atRA-induced
RT   growth inhibition of a novel cell line (HUMEMS) established from
RT   pleural effusion of alveolar rhabdomyosarcoma of breast tissue.";
RL   Hum. Cell 20:39-51(2007).
//
RX   PubMed=20712710; DOI=10.1111/j.1749-0774.2010.00086.x;
RA   Suzuki M., Tominaga N., Ide Y., Ohyama A., Nakahara T., Ishikawa H.,
RA   Tanaka A., Mataga I.;
RT   "Establishment and characterization of the rhabdomyosarcoma cell line
RT   designated NUTOS derived from the human tongue sarcoma: special
RT   reference to the susceptibility of anti-cancer drugs.";
RL   Hum. Cell 23:65-73(2010).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//